Satiety dysfunction in Prader-Willi syndrome demonstrated by fMRI

The neurobiology relating to the insatiable appetite observed in Prader-Willi syndrome (PWS) has not been fully characterised. Two functional magnetic resonance imaging (fMRI) scans were performed on each of three adults with PWS. The scans were carried out pre- and post-treatment with the antiepile...

Full description

Saved in:
Bibliographic Details
Published inJournal of neurology, neurosurgery and psychiatry Vol. 76; no. 2; pp. 260 - 262
Main Authors Shapira, N A, Lessig, M C, He, A G, James, G A, Driscoll, D J, Liu, Y
Format Journal Article
LanguageEnglish
Published London BMJ Publishing Group Ltd 01.02.2005
BMJ
BMJ Publishing Group LTD
BMJ Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The neurobiology relating to the insatiable appetite observed in Prader-Willi syndrome (PWS) has not been fully characterised. Two functional magnetic resonance imaging (fMRI) scans were performed on each of three adults with PWS. The scans were carried out pre- and post-treatment with the antiepileptic topiramate, which had little effect on body weight and appetite in these subjects. Subjects fasted overnight and drank a 75 g dextrose solution prior to fMRI scans for measurement of brain activation levels during/after glucose ingestion. Following glucose administration, there was a significant delay in activation at the hypothalamus and other brain regions associated with satiety compared with previous data on obese volunteers. These regions include the insula, ventromedial prefrontal cortex, and nucleus accumbens. Individuals with PWS showed a mean latency of 24 min while in a previous study obese volunteers had shown a latency of 15 min and lean volunteers a latency of 10 min in the hypothalamus. Our results provide evidence towards a satiety dysfunction in the central nervous system of PWS patients.
Bibliography:href:jnnp-76-260.pdf
ark:/67375/NVC-QGXLPSNR-1
PMID:15654046
istex:A806BEC503E7948998CA42BAEB287CA02B4F1D69
Correspondence to:
 Dr N A Shapira
 P.O. Box 100256, Gainesville, FL 32610–0256, USA; shapira@psychiatry.ufl.edu
local:0760260
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ObjectType-Case Study-2
ObjectType-Feature-4
ObjectType-Report-1
ObjectType-Article-3
ISSN:0022-3050
1468-330X
DOI:10.1136/jnnp.2004.039024